tiprankstipranks
Aperam SA (APEMY)
OTHER OTC:APEMY

Aperam SA (APEMY) AI Stock Analysis

51 Followers

Top Page

APEMY

Aperam SA

(OTC:APEMY)

Select Model
Select Model
Select Model
Neutral 54 (OpenAI - 5.2)
Rating:54Neutral
Price Target:
$40.00
▼(-3.26% Downside)
Action:DowngradedDate:02/08/26
The score is held back primarily by sharply weakened profitability and a stretched P/E driven by near-breakeven earnings, despite resilient (but softening) free cash flow. Technicals are supportive with a strong uptrend, and the earnings call adds moderate support via improving near-term EBITDA guidance and identifiable initiatives, but industry/timing uncertainties remain a key risk.
Positive Factors
Cash generation
Aperam generates positive operating and free cash flow despite near‑breakeven accounting earnings. That durable cash generation funds capex, dividends and the Leadership Journey, reduces refinancing pressure and provides near‑term financial flexibility through a cyclical trough.
Negative Factors
Profitability deterioration
Multi‑year revenue decline and sharp margin compression left net income near zero. The cyclical and capital‑intensive nature of stainless steel means margins can remain depressed absent structural market recovery, constraining earnings power and returns in the medium term.
Read all positive and negative factors
Positive Factors
Negative Factors
Cash generation
Aperam generates positive operating and free cash flow despite near‑breakeven accounting earnings. That durable cash generation funds capex, dividends and the Leadership Journey, reduces refinancing pressure and provides near‑term financial flexibility through a cyclical trough.
Read all positive factors

Aperam SA (APEMY) vs. SPDR S&P 500 ETF (SPY)

Aperam SA Business Overview & Revenue Model

Company Description
Aperam S.A., together with its subsidiaries, engages in the production and sale of stainless and specialty steel products worldwide. It operates through three segments: Stainless & Electrical Steel; Services & Solutions; and Alloys & Specialties. ...
How the Company Makes Money
Aperam makes money primarily by manufacturing and selling stainless steel and specialty steel products. Its core revenue stream is product sales (typically priced per tonne), where realized revenue depends on shipment volumes, product mix (e.g., s...

Aperam SA Earnings Call Summary

Earnings Call Date:Feb 06, 2026
(Q4-2025)
|
% Change Since: |
Next Earnings Date:Apr 30, 2026
Earnings Call Sentiment Positive
The call presents a mix of constructive company-specific progress and near-term market headwinds. Highlights include clear CapEx and investment plans (EUR 200m CapEx in 2026 and EUR 160m site upgrades over 3 years), an articulated Leadership Journey expected to add ~EUR 150m EBITDA (including Universal synergies), a stronger Q1/Q2 EBITDA run-rate (EUR 100m quarterly in H1), improved Brazil performance (EUR ~75m EBITDA) and flexible spare EAF capacity with a 7%–10% potential utilization uplift. Lowlights are primarily market-driven: a Q4 import surge created an H1 inventory overhang, CBAM/trade defense timing and importer behaviors remain uncertain (despite a planned 1 July start), a ~EUR 300/tonne margin gap versus historic averages, and limited forward visibility due to short order books (2.5 months). On balance, company fundamentals, clear targets, capacity to ramp and diversification into alloys/specialties give meaningful upside potential, while the lowlights represent industry and timing risks that management is actively addressing.
Positive Updates
Capacity Utilization and Upside Potential
Current European capacity utilization at Aperam is between 65% and 75%. Management expects a 7%–10% utilization lift from replacement of imports under trade defense measures, and notes flexible electric-arc-furnace (EAF) capacity that can be ramped quickly to capture this upside.
Negative Updates
Import Surge and Inventory Overhang
Significant surge of imports at the end of Q4 created an inventory overhang that is expected to depress demand/put pressure on the market into H1 2026 as distributors draw down stocks.
Read all updates
Q4-2025 Updates
Negative
Capacity Utilization and Upside Potential
Current European capacity utilization at Aperam is between 65% and 75%. Management expects a 7%–10% utilization lift from replacement of imports under trade defense measures, and notes flexible electric-arc-furnace (EAF) capacity that can be ramped quickly to capture this upside.
Read all positive updates
Company Guidance
Management guidance: Q1 EBITDA is expected to be higher than Q4 with a ~EUR100m quarterly run‑rate across H1 2026 (slow start in Q1, ramp in Q2); normalized FY guidance is EUR700–800m (versus a prior ~EUR800m target), built from a 2025 baseline of EUR350m plus ~EUR150m from the Leadership Journey and ~EUR50m of announced investments (full effect by 2029), with the remaining EUR50–75m dependent on trade‑defense/CBAM recovery; CapEx is c. EUR200m in 2026 (including EUR160m of site upgrades over 3 years; continuity CapEx ~EUR150m); current capacity utilization is ~65–75% with safeguard measures expected to lift utilization 7–10%; Brazil delivered ~EUR75m EBITDA in 2025 (low cycle) and higher Brazilian duties (c.12.6%→25%) are expected to add mid‑single‑digit EUR EBITDA per quarter; A&S target ~EUR100m (+ ~EUR60m from Universal and ~EUR9m synergies) and R&R guidance remains around EUR80–85m; order books run ~2.5 months, Q4 import surge may create an H1 overhang, EU trade measures aim to start 1 July 2026, CBAM payments are retroactive to 2027, and nickel exposure is limited with fuel‑alloys positions fully hedged.

Aperam SA Financial Statement Overview

Summary
Income statement weakness is the main drag: multi-year revenue declines and severe margin compression left 2025 net income near breakeven. Balance sheet is still reasonably capitalized, but leverage rose and ROE collapsed. Cash flow is the bright spot with positive operating and free cash flow, though free cash flow has been trending down.
Income Statement
34
Negative
Balance Sheet
56
Neutral
Cash Flow
59
Neutral
BreakdownDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue6.08B6.25B6.59B8.16B5.10B
Gross Profit341.00M449.00M330.00M1.18B1.23B
EBITDA325.62M354.00M364.00M958.00M1.20B
Net Income9.00M231.00M203.00M625.00M968.00M
Balance Sheet
Total Assets5.17B5.84B6.21B6.26B5.91B
Cash, Cash Equivalents and Short-Term Investments324.86M216.00M443.00M457.00M524.00M
Total Debt1.30B760.00M934.00M925.00M990.00M
Total Liabilities1.96B2.47B2.76B2.87B2.96B
Stockholders Equity3.19B3.35B3.44B3.38B2.94B
Cash Flow
Free Cash Flow273.75M125.00M170.00M346.00M398.00M
Operating Cash Flow405.34M280.00M471.00M642.00M550.00M
Investing Cash Flow-565.75M-155.00M-303.00M-297.00M-183.00M
Financing Cash Flow267.99M-336.00M-152.00M-419.00M-197.00M

Aperam SA Technical Analysis

Technical Analysis Sentiment
Positive
Last Price41.35
Price Trends
50DMA
44.16
Positive
100DMA
41.76
Positive
200DMA
36.92
Positive
Market Momentum
MACD
-0.24
Negative
RSI
59.51
Neutral
STOCH
87.09
Negative
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For APEMY, the sentiment is Positive. The current price of 41.35 is above the 20-day moving average (MA) of 40.08, below the 50-day MA of 44.16, and above the 200-day MA of 36.92, indicating a bullish trend. The MACD of -0.24 indicates Negative momentum. The RSI at 59.51 is Neutral, neither overbought nor oversold. The STOCH value of 87.09 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for APEMY.

Aperam SA Peers Comparison

Overall Rating
UnderperformOutperform
Sector (61)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
69
Neutral
$5.11B61.646.07%-16.81%-67.68%
65
Neutral
$44.13B11.035.87%1.03%-4.51%
65
Neutral
$8.10B17.633.53%7.02%-16.69%585.38%
61
Neutral
$10.43B7.12-0.05%2.87%2.86%-36.73%
61
Neutral
$7.27B21.8611.88%1.02%-1.61%-81.36%
61
Neutral
$7.83B29.292.53%2.92%-2.53%-36.08%
54
Neutral
$3.21B286.540.28%5.12%-0.40%-102.89%
* Basic Materials Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
APEMY
Aperam SA
45.15
18.14
67.17%
MT
ArcelorMittal
59.89
33.44
126.41%
CMC
Commercial Metals Company
65.57
24.19
58.45%
GGB
Gerdau SA
4.18
1.79
74.68%
SIM
Grupo Simec SA De CV
29.00
3.25
12.62%
TX
Ternium SA
41.24
16.98
69.99%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Feb 08, 2026